Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 9158572, 6 pages
https://doi.org/10.1155/2017/9158572
Review Article

The Management of Cardiovascular Risk through Epigenetic Biomarkers

1CURS, Laboratoire INSERM U1088, Université de Picardie Jules Verne, chemin du Thil, 80025 Amiens Cedex 1, France
2Interuniversity Center of Phlebolymphology (CIFL), International Research and Educational Program in Clinical and Experimental Biotechnology, University Magna Graecia of Catanzaro, Viale Europa, 88100 Catanzaro, Italy
3Department of Medical and Surgical Sciences, University Magna Graecia of Catanzaro, Viale Europa, 88100 Catanzaro, Italy

Correspondence should be addressed to Raffaele Serra; ti.zcinu@arresr

Received 21 December 2016; Accepted 15 June 2017; Published 13 July 2017

Academic Editor: Klaus Wimmers

Copyright © 2017 Laurent Metzinger et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Laurent Metzinger, Stefano de Franciscis, and Raffaele Serra, “The Management of Cardiovascular Risk through Epigenetic Biomarkers,” BioMed Research International, vol. 2017, Article ID 9158572, 6 pages, 2017. https://doi.org/10.1155/2017/9158572.